CluePoints SVP of Business Development to Speak at Clinical Trials Europe
John Hall, SVP Business Development at CluePoints will share insights into the dimensions of risk associated with Decentralized Clinical Trials (DCTs) at Clinical Trials Europe. The Dimensions of Risk Associated with DCT’s is a Spotlight Session on day 2 of the virtual summit. From 1.35 pm on 3 November, John will share his expertise on the […]
CluePoints Shortlisted for Multiple Awards in Recognition of Pioneering Risk-Based Quality Management Solution
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for three international awards. CluePoints, BioNTech, and Pfizer’s Phase I/II/III study of SARS-COV-2 RNA vaccine BNT162b2 (Comirnaty) has been selected as a finalist for the Clinical Advance of the Year – […]
CluePoints Chief Scientific Officer And Pfizer’s Global RBM Program Lead To Speak At #CQOF2021
Join us at #CQOF2021! As well as hosting a booth at the Clinical Quality Oversight Forum where visitors will be able to learn about our industry-leading Risk-Based Quality Management (RBQM) platform, CluePoints will deliver a co-presentation with Pfizer. Our Chief Scientific Officer, Steve Young will take to the podium with Pfizer’s Risk-Based Monitoring Program Lead, […]
Will ICH E6 (R3) Unleash The Potential Of Risk-Based Trials?
Researchers have been slow to fully adopt innovations designed to overcome the challenges to modern day clinical research, in no small part due to a lack of clarity around their Good Clinical Practice (GCP) use. But an imminent update to the International Harmonization Council’s (ICH) guidelines could be about to change all that and in […]
CluePoints Partners With ZS To Provide Best-In-Class RBQM Expertise And Technology, Increasing Clinical Trial Efficiency And Improving Patient Outcomes
CluePoints, the premier provider of Risk-Based Quality Management software for clinical trials, has partnered with ZS, a global professional services firm with technology and analytics expertise in biopharma, to offer innovative capabilities in portfolio-level performance oversight. The new partnership pairs a best-in-breed solutions company focused on study-level risk-based management with a pharmaceutical and biotech solutions provider with advanced […]
Introducing CluePoints’ Post-COVID Trial Assurance Solution
For well over a year now, the clinical research community has been hard at work to maintain progress in developing new treatments and therapies to improve, protect, extend, and save lives. For many sponsors and CROs, the pandemic has been the catalyst for reassessing pre-existing monitoring protocols to ensure that studies stay on track, particularly […]
Revealing The Bigger Picture Through Metadata & Building RBQM Standards Of The Future
Risk-Based Monitoring (RBM) is the future of clinical trials. Yet, despite significant progress in recent years, many practical challenges remain in making it fully effective. That’s why CluePoints is introducing a new, data-driven dashboard designed to help Sponsors and CROs benchmark projects—not only across protocols and portfolios, but also against industry standards through the CluePoints […]
CluePoints Sponsors RBQM Live, The Definitive Guide To RBQM For Experts And Beginners
Have you heard the news? CluePoints is sponsoring RBQM Live on behalf of the industry! The adoption of Risk-Based Quality Management (RBQM) is accelerating, and it’s more important than ever for the industry to come together and share expertise. Taking place on May 20-21, 2021, this two-day live virtual event is a definitive guide for anyone working […]
Centralized Monitoring: Effective Technology & Documented Evidence Are The Perfect Double Act
If it isn’t documented, it didn’t happen. This mindset has shaped the way clinical monitoring activities, both on-site and remote, are reported and standardized. But as centralized monitoring becomes the norm, how can Sponsors and CROs apply this philosophy to a model built on data-driven oversight? Frédéric Blais, PhD, Director of Central Monitoring at CluePoints, […]
CluePoints To Share COVID-Informed RBQM Best Practice At #SCOPE2021
It has never been more important for the clinical trial community to come together and share best practice – which is why CluePoints is delighted to be taking part in SCOPE 2021. The Summit for Clinical Operations Executives, which will be held online between 2nd and 4th March, 2021, is an opportunity to drive innovation across the […]
